Schmeding M - Search Results

1

Serum chemokine CXC ligand 10 (CXCL10) predicts fibrosis progression after liver transplantation for hepatitis C infection.

Berres ML, Trautwein C, Schmeding M, Eurich D, Tacke F, Bahra M, Neuhaus P, Neumann UP, Wasmuth HE. Berres ML, et al. Among authors: schmeding m. Hepatology. 2011 Feb;53(2):596-603. doi: 10.1002/hep.24098. Epub 2011 Jan 10. Hepatology. 2011. PMID: 21274880

2

Influence of donor/recipient HLA-matching on outcome and recurrence of hepatitis C after liver transplantation.

Langrehr JM, Puhl G, Bahra M, Schmeding M, Spinelli A, Berg T, Schönemann C, Krenn V, Neuhaus P, Neumann UP. Langrehr JM, et al. Among authors: schmeding m. Liver Transpl. 2006 Apr;12(4):644-51. doi: 10.1002/lt.20648. Liver Transpl. 2006. PMID: 16555324

3

Hepatitis C recurrence and fibrosis progression are not increased after living donor liver transplantation: a single-center study of 289 patients.

Schmeding M, Neumann UP, Puhl G, Bahra M, Neuhaus R, Neuhaus P. Schmeding M, et al. Liver Transpl. 2007 May;13(5):687-92. doi: 10.1002/lt.21138. Liver Transpl. 2007. PMID: 17457911

4

Nonresponse to pre-operative chemotherapy does not preclude long-term survival after liver resection in patients with colorectal liver metastases.

Neumann UP, Thelen A, Röcken C, Seehofer D, Bahra M, Riess H, Jonas S, Schmeding M, Pratschke J, Bova R, Neuhaus P. Neumann UP, et al. Among authors: schmeding m. Surgery. 2009 Jul;146(1):52-9. doi: 10.1016/j.surg.2009.02.004. Epub 2009 Apr 21. Surgery. 2009. PMID: 19541010

5

Antiviral treatment of patients with recurrent hepatitis C after liver transplantation with pegylated interferon.

Schmidt SC, Bahra M, Bayraktar S, Berg T, Schmeding M, Pratschke J, Neuhaus P, Neumann U. Schmidt SC, et al. Among authors: schmeding m. Dig Dis Sci. 2010 Jul;55(7):2063-9. doi: 10.1007/s10620-009-0982-2. Epub 2009 Oct 2. Dig Dis Sci. 2010. PMID: 19798575

6

Aging of the liver graft and functional quality in the absence of recurrent disease: a 10 year histological follow-up.

Schmeding M, Sauer I, Hartwig K, Theruvath T, Pratschke J, Neuhaus R, Neuhaus P, Neumann UP. Schmeding M, et al. Ann Transplant. 2010 Jan-Mar;15(1):5-13. doi: 10.12659/aot.880562. Ann Transplant. 2010. PMID: 20305312 Review.

7

ELISA-based detection of C4d after liver transplantation--a helpful tool for differential diagnosis between acute rejection and HCV-recurrence?

Schmeding M, Kienlein S, Röcken C, Neuhaus R, Neuhaus P, Heidenhain C, Neumann UP. Schmeding M, et al. Transpl Immunol. 2010 Aug;23(4):156-60. doi: 10.1016/j.trim.2010.06.002. Epub 2010 Jun 14. Transpl Immunol. 2010. PMID: 20558292

8

Mycophenolate mofetil monotherapy in liver transplantation: 5-year follow-up of a prospective randomized trial.

Schmeding M, Kiessling A, Neuhaus R, Heidenhain C, Bahra M, Neuhaus P, Neumann UP. Schmeding M, et al. Transplantation. 2011 Oct 27;92(8):923-9. doi: 10.1097/TP.0b013e31822d880d. Transplantation. 2011. PMID: 21832958 Clinical Trial.

9

A 7-gene signature of the recipient predicts the progression of fibrosis after liver transplantation for hepatitis C virus infection.

do O NT, Eurich D, Schmitz P, Schmeding M, Heidenhain C, Bahra M, Trautwein C, Neuhaus P, Neumann UP, Wasmuth HE. do O NT, et al. Among authors: schmeding m. Liver Transpl. 2012 Mar;18(3):298-304. doi: 10.1002/lt.22475. Liver Transpl. 2012. PMID: 22139994

10

Liver transplantation for intra- and extrahepatic cholangiocarcinoma.

Schmeding M, Neumann UP. Schmeding M, et al. Ann Transplant. 2013 Jan 4;18:1-8. doi: 10.12659/AOT.883789. Ann Transplant. 2013. PMID: 23792495 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results